FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Mar. 29, 2016-- MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Mid-Missouri Neonatology, LLC, a private neonatal physician group practice based in Columbia, Mo.

Mid-Missouri Neonatology, LLC was founded in 1997 and employs 3 full-time neonatologists. The practice provides delivery, neonatal, newborn nursery, pediatric and consultative services at Boone Hospital Center, a 21 bed Level III NICU. Once integrated, full-time neonatal nurse practitioners will be added to support growth of the practice.

“MEDNAX’s robust clinical database, as well as the company’s emphasis on research, education and quality initiatives, has advanced neonatal care on a national scale,” said Timothy O’Connor, M.D., who will serve as medical director. “As a group focused on providing parent and patient-centered care, we know MEDNAX will provide us with the infrastructure and other support we need to further enhance the services we have been providing in our community for more than 20 years.”

This acquisition adds to the services MEDNAX provides in Missouri across multiple specialties which include maternal-fetal, neonatal, cardiac and hearing screen services.

This practice was acquired for cash and the transaction is expected to be immediately accretive to earnings. No additional terms of this transaction was disclosed.

ABOUT MEDNAX

MEDNAX, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,300 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at www.mednax.com.

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160329005370/en/

Source: MEDNAX, Inc.

MEDNAX, Inc.
Charles Lynch, 954-384-0175, Ext. 5692
Vice President, Strategy and Investor Relations
charles_lynch@mednax.com